DLK1(PREF1) is a negative regulator of adipogenesis in CD105

Abstract
The main physiological function of adipose-derived stromal/progenitor cells (ASC) is to differentiate into adipocytes. ASC are most likely localized at perivascular sites in adipose tissues and retain the capacity to differentiate into multiple cell types. Although cell surface markers for ASC have been described, there is no complete consensus on the antigen expression pattern that will precisely define these cells. DLK1(PREF1) is an established marker for mouse adipocyte progenitors which inhibits adipogenesis. This suggests that DLK1(PREF1) could be a useful marker to characterize human ASC. The DLK1(PREF1) status of human ASC is however unknown. In the present study we isolated ASC from the heterogeneous stromal vascular fraction of subcutaneous abdominal fat pats of adult women. These cells were selected by their plastic adherence and expanded to passage 5. The ASC were characterized as relatively homogenous cell population with the capacity to differentiate in vitro into adipocytes, chondrocytes, and osteoblasts and the immunophenotype CD105 plays a role in the regulation of adipogenesis in these cells RNAi-mediated knockdown experiments were conducted. Knockdown of DLK1(PREF1) in differentiating ASC resulted in a significant increase of the expression of the adipogenic key regulator PPARγ2 and of the terminal adipogenic differentiation marker FABP4. We conclude that DLK1(PREF1) is well expressed in human ASC and acts as a negative regulator of adipogenesis. Moreover, DLK1(PREF1) could be a useful marker contributing to the characterization of human ASC.
Introduction
White adipose tissues are the primary triglyceride/energy storages of the body acting as metabolic regulator in glucose homeostasis and lipid metabolism [1] , and as endocrine organ [2] . The main cell type in fat tissues fulfilling these functions is the mature adipocyte. In adult humans approximately 10 % of fat cells in adipose depots are renewed annually [3] , and surgical removal of fat tissue in rodents induces compensatory recovery [4] . This indicates a high demand of progenitor cells for renewal and, hence, maintenance of adipose tissue functions. In fact, the number of adipocyte progenitors in a given fat tissue can vary between 15-40 % of the cell population dependent on the tissue type, localization in the body, physiological conditions, and age [2, 5, 6] .
White adipocyte progenitor cells were identified in vivo [7] , and evidence provided by several studies indicates that these cells are responsible for regenerating adipocyte numbers in fat tissues [7] [8] [9] [10] [11] [12] . In addition to adipocyte hypertrophy, an increased proliferation and adipogenic differentiation of ASC also contributes to the adipose tissue growth that is characteristic for obesity [12] [13] [14] . ASC reside most likely at perivascular sites in adipose tissues [15] [16] [17] . The number of intermediate stages between adipose progenitors and mature adipocytes is uncertain but once committed, ASC can enter an adipocyte differentiation program (adipogenesis) to acquire their specific functions as adipocytes [18] [19] [20] . Adipogenesis in human ASC involves growth arrest, early and terminal differentiation, including morphological changes, lipid accumulation and the expression of fat cell specific genes, for example fatty acid binding protein- 4 (FABP4) and adipokines, such as leptin and adiponectin. The stages of adipocyte differentiation are orchestrated by a transcriptional cascade involving adipogenic keyfactors, such as the nuclear receptor peroxisome proliferator-activated receptor-γ2 (PPARγ2) and members of the CCAAT/enhancer-binding protein (C/EBP) family [18, 20] .
Adipose-derived stromal cells (ASC) are most frequently isolated by collagenase digestion of white adipose tissue, yielding a stromal vascular fraction (SVF) which contains a mixture of heterogeneous cell types that are further purified by differential centrifugation, plating and plastic adherence [10, 11, 21] . It has been shown that a single adherent cell derived from the SVF can be expanded generating a daughter cell population with multipotent differentiation capacity, defined
as an adult stem cell [21, 22] Delta-like protein 1/Preadipocyte factor-1 (DLK1/PREF1), which was originally identified as an inhibitor of adipogenesis in the murine preadipocyte cell line NIH 3T3-L1 [30] , is used as preadipocyte marker [7, 17, [30] [31] [32] . Similar to Notch, DLK1(PREF1) is an epidermal growth factor repeat containing transmembrane protein that is proteolytically converted at the extracellular domain to generate a physiologically active soluble form that inhibits adipocyte differentiation [33] . Adipocyte progenitors are the sole cell type expressing DLK1(PREF1) in mouse adipose tissues. DLK1(PREF1) knockout mice show accelerated fat deposition, whereas mice overexpressing DLK1(PREF1) in adipose tissue exhibit decreased fat mass [12, [33] [34] [35] [36] . DLK1(PREF1) was shown to play a role in the regulation of cell commitment and differentiation in murine multipotent mesenchymal cells, regulating fat mass and bone mass formation in vivo [34, [36] [37] [38] [39] . DLK1(PREF1) can also stimulate bone resorption in mice [38] . DLK1(PREF1) suppresses C/EBP and C/EBP gene expression in mouse preadipocytes which leads to prevention of adipogenesis [37] . Moreover, DLK1(PREF1) can direct murine multipotent mesenchymal cells to the chondrogenic lineage but it inhibits differentiation into osteoblasts as well as chondrocytes [37, 40, 41] . DLK1(PREF1) was also shown to be expressed in human bone marrow-derived (BM) mesenchymal stem cells (MSC), but at relatively low levels [38, [42] [43] [44] . It keeps these cells in an undifferentiated state and regulates their differentiation into osteoblasts or adipocytes, at least in part by influencing their microenvironment composition [38, [42] [43] [44] . Low expression of DLK1(PREF1) was also found in human cord blood (CB) MSC correlating with strong adipogenic differentiation [45] . Moreover, DLK1(PREF1) overexpression inhibits adipogenesis as well as osteogenesis in CB MSC [45] . Together these data suggest that DLK1(PREF1) is an important regulator of mesenchymal stem cell differentiation. Thus DLK1(PREF1) could be a useful marker to characterize human ASC, however, the DLK1(PREF1) status of these cells is unknown.
In the present study, we isolated defined populations of ASC from human abdominal subcutaneous fat tissue derived from 4 different women. The immunophenotype and the in vitro differentiation capacity of these cells was analysed after expansion in medium with low concentrations of FBS until passage 5. Moreover, the significance of DLK1(PREF1) for adipogenic differentiation of these cells was studied.
Material and methods
Subjects
Subcutaneous adipose tissue pads (~100 g wet weight) were obtained by incision from four women undergoing elective plastic abdominal surgery. [46, 47] The age of the donors was between 30 and 47 years. The body mass index of the subjects was between 22 -27 kg/m 2 . All participants gave their informed written consent, and the protocol was approved by the ethical committee of Innsbruck Medical University, Austria.
Isolation of human adipose-derived stem cells
The adipose precursor cells were isolated essentially as described [10, 48] . Immediately after surgery adipose tissue biopsies were transferred into sterile serum-free ASC medium (DMEM/F- 
Cell culture
The ASC were expanded essentially as described [49] . Briefly the cells were washed with PBS and trypsinized using 0.5% trypsin-EDTA 1x (Gibco, Vienna, Austria). Trypsin was removed by centrifugation at 300 RCF for 5 min and the cells seeded in a density of 5000 cells/cm 2 in ASC medium plus 10% FBS and maintained at 37°C with 5% CO 2 . 16h later the medium was replaced by PM4 medium (ASC medium containing 2.5% FBS, 10ng/ml EGF, 1ng/ml bFGF, 500ng/ml Insulin) [49] . ASC were passaged at a ratio of 1:2, medium was changed every third day and the cells were grown to 70% confluence before splitting. Population doublings (PDL) were calculated cells/ml, slowly brought to -80°C and then stored in frozen nitrogen. After thawing cryomedium was immediately removed by centrifugation.
Adipogenic differentiation
For the induction of adipogenesis the ASC were seeded at a density of 10,000 cells/cm washing was carried out twice with distilled water.
Osteogenic differentiation
For induction of osteogenesis ASC were seeded at a density of 20,000 cells/cm 
Chondrogenic differentiation
The ASC were seeded in 5 separate 5µl droplets of ASC medium plus 10% FBS, each containing 16,000 cells per 9.6 cm 2 well. After 2 hours each well was carefully filled with 2 ml of STEMPRO Osteocyte/Chondrocyte Differentiation Basal Medium combined with STEMPRO Chondrogenesis Supplement (Gibco, Vienna, Austria). Medium was replaced every second day.
After 21 days chondrocytes were fixed with 4% paraformaldehyde (Sigma) in PBS for 30 minutes, washed with PBS and stained with 1% Alcian-Blue 8GX (Molekula, Taufkirchen, Germany) in 0.1N HCl for 30 minutes. Final washing was done three times with 0.1N HCl and two times with distilled water.
Cultivation of human foreskin fibroblasts, HUVEC, and PBMCs
Human foreskin fibroblasts and human umbilical vein endothelial cells (HUVEC) were isolated and cultivated essentially as described [50] . PBMCs were prepared and cultivated as described [51] .
Quantitative RT-PCR
Total RNA was isolated with the RNeasy Micro Kit (Qiagen, Hilden, Germany), and cDNA synthesis was performed with the First Strand cDNA Synthesis Kit (Fermentas, St.Leon-Rot, Germany). Quantitative expression analysis was performed using the LightCycler® 480 RealTime PCR System (Roche, Vienna, Austria). The mRNA quantification was performed using actin or TATA binding protein (TBP) for normalization. Primers: The sequences, genbank accession numbers, and the base numbers of the primers within the sequence are indicated in table 1.
Immuofluorescence experiments
Immunofluorescence experiments were conducted as described [52] . Briefly, cells were fixed with 
Westernblot analysis
Cell lysates were prepared in sample buffer (2% SDS, 6% glycerine, 0,1M DTT, 0,5% bromphenol-blue, 62.5mM Tris-HCl pH 6.8), separated by SDS-PAGE and western blot analysis was performed essentially as described [53] . Biosystems, Vienna).
Retroviral gene expression system
5 different pLKO.1 lentiviral DLK1(PREF1) shRNA vectors for accession NM_003836
(#RHS4533, Open Biosystems, Vienna) were used for lentiviral particle production employing the ViraPowerTM Lentiviral Expression System (Invitrogen, Lofer, Austria) and a second-generation system provided by the Trono lab (Addgene, Cambridge, USA). The same procedure was used to generate virus particles of the DLK1(PREF1) overexpressing lentivirus pLentiDLK1(PREF1).
The purified viral particles were stored at -80°C. For viral infection, 900,000 ASC were seeded in a 75-cm 2 bottle, with 8 ml medium, 6 µg/ml polybrene and virus particles at a multiplicity of infection (MOI) of 1:4. After 24 h, the medium was changed, and the cells were grown for another 48 h before they were trypsinized and seeded at 10,000 cells/cm 2 for subsequent differentiation.
The efficiency of the DLK1(PREF1) knockdown was measured by qRT-PCR and Western blot analysis 4 days after infection or later. The most efficient knockdown clones for DLK1(PREF1) (sh#2 and sh#3) which were identified by qRT-PCR and Western blotting were used for further experiments.
Flow cytometry analysis
SVF and trypsinized early passage ASC, 250,000 cells per sample, were simultaneously fixed and permeabilized using BD Cytofix/Cytoperm™ solution to prepare the cells for intracellular and surface marker staining. The cells were subjected to immunofluorescence staining using a panel of directly conjugated mouse monoclonal antibodies: CD31-FITC-A (WM59) #557508, CD34-PECy7A (581) #560710, CD90-PE-A (5E10) #555596, CD105-PerCP-Cy5-5-A (266) #560819; BD Pharmingen, Heidelberg) For DLK1/PREF1 immunofluorescence staining a rat monoclonal anti human DLK1/PREF1 antibody (AG-25A-0091, Adipogen, San Diego) was used in combination with an anti-rat-APC-A antibody (BD Pharmingen, Heidelberg, #551019). The labeled cells were measured using a FACSCanto II (BD Biosciences) and the data were analyzed using the FACSDiva software (BD Biosciences).
Results
Immunophenotype of human ASC derived from abdominal subcutaneous fat pads
Fresh human abdominal subcutaneous fat pads obtained by surgical resection were processed for the isolation of the stromal-vascular cell fraction (SVF) (Supplemental Fig. 1A ), essentially as described [10, 28, 48] . 1D ). CD34 is not expressed in MSCs [56] , but in both hematopoietic [57] and endothelial [58] progenitors (Supplemental Fig. 1D ). CD31 (PECAM-1) is a marker for endothelial cells [54, 59] (Supplemental Fig. 1D ). Our ASC highly expressed CD90, CD105 and CD34 but not CD31 (Fig.   1A ), as shown previously [23] . We found that a considerable proportion of CD105 was not localized on the cell surface but in intracellular structures. To identify these structures we costained the ASC with antibodies against CD105 in combination with antibodies against either calnexin, a protein of the endoplasmatic reticulum (ER), or GM130, a protein of the Golgi apparatus. Confocal microscopy analysis demonstrated that considerable proportions of CD105 co-localized with structures of the Golgi apparatus as well as the ER (Fig. 1B) . DLK1(PREF1) is an established marker for mouse adipocyte progenitors [33] . The DLK1(PREF1) status of human ASC is unknown. Indirect immunofluorescence experiments demonstrated that all cells in the ASC population at passage 5 stained strongly positive for DLK1(PREF1) (Fig. 1A) . Since DLK1(PREF1) was identified as novel marker protein for human ASC it was interesting to monitor the purification of DLK1(PREF1) positive cells during enrichment of the ASC from the SVF and sub cultivation to passage 6 by FACS analysis (Fig. 1D, upper panel) . In the SVF we detected 41. qRT-PCR in the cell mixture of the SVF and the isolated ASC. We found a 2.5 fold increase in the CD90 expression (Fig. 1E) , suggesting that CD90 + stem cells are enriched. In contrary, CD31 mRNA expression was 3 times reduced in the ASC population (Fig. 1E) , most likely reflecting the removal of floating endothelial cells.
To determine the amount of adipocyte committed and/or differentiated cells in the ASC fraction the expression levels of the adipogenic differentiation marker FABP4 was measured (Fig.   1F ). FABP4 mRNA was not detectable in the ASC fraction, suggesting that adipoyctes were removed during purification. In summary, the isolated ASC were characterized as (Fig. 2A) . Confocal immunofluorescence microscopy analysis demonstrated that the ASC marker DLK1(PREF1) was highly expressed in proliferating ( Fig. 2A, top panel) and to a similar extent in density-arrested ASC, which stay in the G0/G1 phase of the cell cycle at day 0 of differentiation ( Fig. 2A , middle left panel). After 14 days of differentiation the DLK1(PREF1) protein was almost undetectable (Fig. 2A, bottom left panel) . In contrast, the adipogenic differentiation marker FABP4 was not detectable at day 0 but strongly induced at day 14 of differentiation ( Fig. 2A, right panel) . The strong reduction of DLK1(PREF1) and induction of FABP4 during differentiation was corroborated at the mRNA level by qRT-PCR (Fig. 2B) and by western blot analysis (Fig. 2C) . qRT-PCR analysis also demonstrated that the expression of the adipogenic keytranscription factors PPARγ2 (Fig. 2D ) and C/EBP (Fig. 2E ) was strongly induced during adipogenesis. Moreover, two terminal adipogenic differentiation markers, the adipokines adiponectin and leptin, were well induced in the ASC at day 9 of differentiation ( Fig.   2F and 2G ). To finally assess the ability of the ASC to differentiate in in vitro assays into other mesenchymal lineages, ASC were put under chondrogenic, osteogenic and adipogenic differentiation conditions (Fig. 2H ). As expected, based on their tissue of origin, the ASC underwent strong adipogenic differentiation, shown by Oil RedO staining of the formed lipid droplets. We detected differences in the strength of the in vitro adipogenic maturation of single ASC isolated from the same depot, as reflected by the difference in the quantity and size of lipid droplets (Fig. 2H , compare white and yellow arrows). Staining of the glucosaminoglycans in chondrocytes with Alcian Blue and of the osteocyte specific calcification with Alizatin Red S demonstrated that the ASC could differentiate in all three mesenchymal cell types in vitro.
Although these findings warrant further studies, employing a chondrogenic assay in a pellet culture and an osteogenic assay best done by in vivo transplantation, they suggest that clones isolated from our purified cell population most likely fulfill the criteria of adult tissue-specific multipotent stem cells [11, 48, 54, 56, 60 ].
DLK1(PREF1) negatively regulates adipogenesis in human ASC
To better understand the function of DLK1(PREF1) in human ASC biology, we studied the effect of DLK1(PREF1) shRNA knockdown on the adipogenic differentiation potential of ASC.
DLK1(PREF1) was knocked down using two different shRNA constructs for DLK1(PREF1) mRNA, sh#2 and sh#3 (Fig. 3) . A strong reduction of DLK1(PREF1) mRNA was found in sh#2-and sh#3-containing ASC (Fig. 3A) and DLK1(PREF1) protein was significantly reduced by both sh#2 and sh#3 (Fig. 3B ). ASC infected with a DLK1(PREF1) overexpressing lentivirus, pLentiDLK1(PREF1), served as positive control (Fig. 3B) . The effects of the DLK1(PREF1) knockdown on the induction and progression of adipogenesis were monitored by assessing the expression of the key adipogenic regulator PPAR2 and of the terminal adipogenic differentiation product FABP4. We found a significant increase in the induction of PPARγ2 and FABP4 expression in the DLK1(PREF1) knockdown cells at day 3 of adipogenesis compared to the control cells (Fig. 3C) . We conclude that the knockdown of DLK1(PREF1) enhances adipogenic differentiation in human ASC.
Discussion
In the present study we isolated ASC populations from subcutaneous abdominal fat pats of homogeneous ASC and ASC fractions are used as defined cell population in clinical studies [27] .
Although specific pattern of cellular surface markers were assigned to human ASC [21, [23] [24] [25] [26] , some debate over the criteria defining a human ASC remains and a consensus on minimal obligatory criteria for ASC has not yet been defined. In keeping with the immunophenotype defined by the International Society for Cell Therapy for mesenchymal stromal cells (MSCs) [61] , the vast majority of our ASC robustly expressed the MSC markers CD90 and CD105 [54] and were negative for the endothelial cell marker CD31 [54, 59] . CD34, a transmembrane glycoprotein, is known as a marker for human hematopoietic [57] and endothelial [58] progenitors. In contrast to MSCs [56] our ASC stained strongly positive for CD34. This result is in keeping with previous studies from other research groups [15, 23, 25, 28, 62, 63] . In our ASC CD34 was at peak after 21 days of cultivation at passage 5 and expression remained stable even after passaging the ASC for 82 days until passage 15. The stable expression of CD34 in later passages is in contrast to a previous study showing the loss of CD34 at early ASC passages [21] .
However, in that study the ASC were cultivated in 10 % FBS. The employment of growth medium with 2.5 % FBS in our study could account for these differences. It is known that longterm cultivation of cells in high concentration of FBS leads to changes in the proliferation and differentiation phenotype induced by mitogenic growth factors, survival factors and differentiation controlling signals [29, 64] . This leads to changes in cell specific markers as well as in the terminal differentiation capacity [49] . Similar to our results a recent study by Maumas et al., [62] demonstrated the maintenance of the CD34 cell surface marker in ASC cultured in 2 % FBS and the loss of CD34 in 10 % FBS. Thus our and other studies [15, 23, 25, 28, 62] accessory receptor for TGFβ [65] , was not analyzed in the study by Zimmerlin et al., [15] . In accordance with previous studies [24, 66] CD105 was highly expressed in our passage 5 ASC.
Some studies found increasing expression of CD105 during early passaging of ASC in growth medium with 10 % FBS [21] . Similarly, human BM MSCs show higher levels of stromal markers, including CD105, in later stages of culture [56] . Conflicting results came from one study using We analyzed whether DLK1(PREF1), that was firstly identified as a putative marker for murine preadipocytes [30] , could be used as additional marker to characterize human ASC. We found that DLK1(PREF1) is highly expressed in human ASC. The DLK1(PREF1) protein levels were similar in human ASC proliferating in PM4 medium and in density-arrested G0/G1-phase ASC. In the course of adipogenic differentiation the DLK1(PREF1) protein level declined.
DLK1(PREF1) was almost undetectable in adipocytes 14 days after the induction of adipocyte differentiation. Thus DLK1(PREF1) is expressed in proliferating ASC, in density-arrested ASC, and most likely at early stages of adipogenic differentiation but completely downregulated in human adipocytes. During adipogenic differentiation of MEFs (mouse embryonic fibroblasts) the DLK1(PREF1) protein levels are relatively low in density arrest before differentiation, transiently increased at day 1 and 2, and then decreased and undetectable at day 5 after conversion into adipocytes [37] . Similar in adipogenesis of the preadipocyte cell line NIH 3T3 L1 the DLK1(PREF1) protein levels are low in density arrest before differentiation and transiently increase until day 2 -3 [67] . When these cells cease clonal expansion and enter terminal adipogenic differentiation [20] , the DLK1(PREF1) protein levels decrease but membranous forms of DLK1(PREF1) are detectable until day 5 [67] . Thus certain forms of DLK1(PREF1) protein are still present at early stages of terminal adipogenic differentiation and most likely contribute to adipocyte differentiation [67] . DLK1(PREF1) has been identified as a negative regulator of adipocyte differentiation in mouse preadipocytes [30] . Moreover, in its active form, DLK1(PREF1) was shown to function in an autocrine and paracrine manner as soluble factor to inhibit differentiation of murine multipotent MSCs into adipocytes, osteoblasts and chondrocytes [37, 68] . This suggests that DLK1(PREF1) has a general role in keeping mouse precursor cells in an undifferentiated state. In the present study we found that DLK1(PREF1) functions as negative regulator of adipogenesis in human ASC. Previous studies have identified DLK1(PREF1) as regulator of differentiation in human BM MSCs [42, 44] and CB MSCs [45] . DLK1(PREF1) was used as a marker to distinguish human unrestricted somatic stem cells and CB MSC [45] .
Moreover, DLK1(PREF1) was employed as surface marker for the isolation and differentiation of chondrogenic cells derived from human embryonic stem cells [41] . DLK1(PREF1) is also involved in additional differentiation processes in rodent cells, including haematopoiesis [69] , pancreatic islet cell differentiation [70] , Schwann cell differentiation [71] , hepatic cell differentiation [72] , and differentiation of muscle satellite cells. Moreover, DLK1(PREF1) is earlier [12] .
Studies in mice suggest that the age, depot site and sex of the donor can influence the features and functionality of the derived ASC [5, 73, 74] . Clinical studies found a correlation between donor age and differentiation capacitiy of the given ASC [75] [76] [77] . In humans also an influence of the BMI [78] and fat depot origin [79, 80] on ASC features was shown. In the present study, we isolated ASC from subcutaneous adipose tissue pads of four different women with an age between 30 -47 years and a BMI between 22 -27 kg/m 2 . No differences in the analyzed cell surface marker patterns were found between the ASC from the abdominal subcutaneous depots of the different donors. Moreover, all ASC populations had a high capacity to differentiate into adipocytes in vitro, as demonstrated by the formation of high levels of four terminal adipogenic differentiation products, FABP4, adiponectin, leptin and triglycerides. This suggests that the relatively small differences in age and BMI between our four donors did not account for major differences in these ASC features. We detected however differences in the strength of the adipogenic maturation at the level of single ASC isolated from the same depot. This was reflected by the difference in the quantity and size of lipid droplets formed 20 days after the induction of adipogenesis (Fig. 2H , compare white and yellow arrows). These findings are in keeping with the differences in the single cell FABP4 protein level (Fig. 2A , compare white and yellow arrows).
These data suggest that there may be heterogeneity regarding the adipogenic capacity of ASC regarding the differentiation capacity was previously shown [15, 81, 82] . Common observations in our study were islets of strongly differentiated ASC surrounded by areas of weaker differentiated ASC. This could, for example, result from differences in the autocrine/paracrine micromilieu caused by a different cell density. Such findings could mirror the existence of different subtypes of ASC in subcutaneous fat depots in vivo, as discussed previously [12] . More studies are necessary to better understand these observations.
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